PMID- 25079102 OWN - NLM STAT- MEDLINE DCOM- 20141215 LR - 20220409 IS - 1474-5488 (Electronic) IS - 1470-2045 (Linking) VI - 15 IP - 9 DP - 2014 Aug TI - EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. PG - e395-403 LID - S1470-2045(14)70011-7 [pii] LID - 10.1016/S1470-2045(14)70011-7 [doi] AB - This guideline provides recommendations for diagnostic and therapeutic procedures for patients with malignant gliomas. We differentiate evidence-based standards from reasonable options or non-evidence-based measures that should no longer be considered. The recommendations herein should provide a framework and assurance for the choice of diagnostic procedures and therapeutic measures and aim to reduce complications from unnecessary treatment and cost. The guideline contributes to a critical appreciation of concurrent drugs with a focus on the controlled use of anticonvulsants and steroids. It should serve as a guideline for all professionals involved in the diagnostics and care of glioma patients and also as a source of knowledge for insurance companies and other institutions involved in the cost regulation of cancer care in Europe. Implementation of the recommendations summarised here will need interdisciplinary structures of care for patients with brain tumours and structured processes of diagnostic and therapeutic procedures. CI - Copyright (c) 2014 Elsevier Ltd. All rights reserved. FAU - Weller, Michael AU - Weller M AD - Department of Neurology, University Hospital Zurich, Zurich, Switzerland. Electronic address: michael.weller@usz.ch. FAU - van den Bent, Martin AU - van den Bent M AD - Neurooncology Unit, Erasmus MC Cancer Institute, Rotterdam, Netherlands. FAU - Hopkins, Kirsten AU - Hopkins K AD - Bristol Haematology and Oncology Centre, Bristol, UK. FAU - Tonn, Jorg C AU - Tonn JC AD - Department of Neurosurgery, University of Munich LMU, Munich, Germany. FAU - Stupp, Roger AU - Stupp R AD - Department of Oncology, University Hospital Zurich, Zurich, Switzerland. FAU - Falini, Andrea AU - Falini A AD - Department of Neuroradiology, Scientific Institute San Raffaele Hospital and University Vita-Salute San Raffaele, Milan, Italy. FAU - Cohen-Jonathan-Moyal, Elizabeth AU - Cohen-Jonathan-Moyal E AD - Departement de Radiotherapie, Institut Claudius Regaud, Toulouse, France. FAU - Frappaz, Didier AU - Frappaz D AD - Neurooncologie Adulte et Pediatrique, Centre Leon Berard, Lyon, France. FAU - Henriksson, Roger AU - Henriksson R AD - Regional Cancer Center Stockholm Gotland and Department of Radiation Sciences and Oncology, Umea University Hospital, Sweden. FAU - Balana, Carmen AU - Balana C AD - Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Carretera Canyet sn, Badalona, Spain. FAU - Chinot, Olivier AU - Chinot O AD - Aix-Marseille Universite, Department of Neuro-Oncology, CHU Timone, Marseilles, France. FAU - Ram, Zvi AU - Ram Z AD - Department of Neurosurgery, Tel Aviv Medical Center, Tel Aviv, Israel. FAU - Reifenberger, Guido AU - Reifenberger G AD - Department of Neuropathology, Heinrich Heine University Dusseldorf, Dusseldorf, Germany; German Cancer Consortium, partner site Essen/Dusseldorf, Dusseldorf, Germany. FAU - Soffietti, Riccardo AU - Soffietti R AD - Department of Neuro-Oncology, University Hospital, Turin, Italy. FAU - Wick, Wolfgang AU - Wick W AD - Department of Neurooncology, Neurology Clinic & National Center for Tumor Diseases, University Hospital Heidelberg, Germany; German Consortium of Translational Cancer Research, Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg, Germany. CN - European Association for Neuro-Oncology (EANO) Task Force on Malignant Glioma LA - eng PT - Journal Article PT - Practice Guideline PL - England TA - Lancet Oncol JT - The Lancet. Oncology JID - 100957246 SB - IM EIN - Lancet Oncol. 2014 Dec;15(13):e587 EIN - Lancet Oncol. 2014 Dec;15(13):e587. PMID: 31288373 MH - Aged MH - Aged, 80 and over MH - Brain Neoplasms/*diagnosis/mortality/*therapy MH - Combined Modality Therapy MH - Europe MH - Evidence-Based Medicine MH - Female MH - Glioblastoma/*diagnosis/mortality/*therapy MH - Glioma/*diagnosis/mortality/*therapy MH - Humans MH - Male MH - Middle Aged MH - Prognosis MH - Risk Assessment MH - Societies, Medical MH - Survival Analysis EDAT- 2014/08/01 06:00 MHDA- 2014/12/17 06:00 CRDT- 2014/08/01 06:00 PHST- 2014/08/01 06:00 [entrez] PHST- 2014/08/01 06:00 [pubmed] PHST- 2014/12/17 06:00 [medline] AID - S1470-2045(14)70011-7 [pii] AID - 10.1016/S1470-2045(14)70011-7 [doi] PST - ppublish SO - Lancet Oncol. 2014 Aug;15(9):e395-403. doi: 10.1016/S1470-2045(14)70011-7.